Quick Answer
OS Therapies Inc reported Stockholders Equity of -$6.10 million for the year ending 2025.
- OS Therapies Inc showed a decrease of -86.6% in Stockholders Equity from 2024 to 2025.
- This data is from OS Therapies Inc's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: -$18.74 million | Q2 2023: -$21.27 million | Q3 2023: -$22.52 million | Q1 2024: -$25.51 million | Q2 2024: -$27.06 million | Q3 2024: -$707.1 thousand | Q1 2025: -$4.19 million | Q2 2025: $4.94 million | Q3 2025: $3.64 million.
- Over the full 4 years of available data (2022 to 2025), OS Therapies Inc's Stockholders Equity has grown by 65.3%.
- Historical annual values: Fiscal year 2025: -$6.10 million | Fiscal year 2024: -$3.27 million | Fiscal year 2023: -$24.02 million | Fiscal year 2022: -$17.56 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: